{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:41:22Z","timestamp":1773877282362,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":3148,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Abbott Molecular Laboratories"},{"name":"Innovation, Development, and Progess Foundation"},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Abbott Molecular Laboratories"},{"name":"Neogenomics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.jmoldx.2011.01.011","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T16:13:20Z","timestamp":1303316000000},"page":"352-358","source":"Crossref","is-referenced-by-count":70,"title":["Copy Number Gains in 11q13 and 8q34 Are Highly Linked to Prognosis in Cutaneous Malignant Melanoma"],"prefix":"10.1016","volume":"13","author":[{"given":"Pedram","family":"Gerami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S.","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Pouryazdanparast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery D.","family":"Wayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Haghighat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus J.","family":"Busam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2011.01.011_bib1","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib2","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0050120","article-title":"Improving melanoma classification by integrating genetic and morphologic features","volume":"5","author":"Viros","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib3","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2007.14.0707","article-title":"Major response to imatinib mesylate in KIT-mutated melanoma","volume":"26","author":"Hodi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib4","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.1158\/1078-0432.CCR-08-1144","article-title":"Imatinib targeting of KIT-mutant oncoprotein in melanoma","volume":"14","author":"Jiang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1755-148X.2008.00475.x","article-title":"Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation","volume":"21","author":"Lutzky","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib6","first-page":"2170","article-title":"Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization","volume":"58","author":"Bastian","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib7","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e3181a1ef36","article-title":"Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archderm.144.9.1235-b","article-title":"Cyclin D1 homogeneous staining regions by fluorescent in situ hybridization: a possible indicator of aggressive behavior in melanomas","volume":"144","author":"Gerami","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/DAD.0b013e31819f8316","article-title":"Malignant melanoma with monster cells showing massive cyclin D1 amplification","volume":"31","author":"Pouryazdanparast","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.bjc.6604940","article-title":"Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours","volume":"100","author":"Tovey","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1078-0432.CCR-09-1660","article-title":"Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer","volume":"16","author":"Dahabreh","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature08658","article-title":"A comprehensive catalogue of somatic mutations from a human cancer genome","volume":"463","author":"Pleasance","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib13","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0019-509X.13769","article-title":"FISH for HER-2\/neu in breast cancer: standardization makes the difference!","volume":"41","author":"Gokhale","year":"2004","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib15","series-title":"Basic Pathology","author":"Kumar","year":"1997"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jnci\/djq037","article-title":"BRAF inhibitors: research accelerates in wake of positive findings","volume":"102","author":"Brower","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmoldx.2011.01.011_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2217\/fon.09.56","article-title":"Development of a novel chemical class of BRAF inhibitors offers new hope for melanoma treatment","volume":"5","author":"Smalley","year":"2009","journal-title":"Future Oncol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157811000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157811000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T11:51:01Z","timestamp":1686052261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157811000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1525157811000705"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2011.01.011","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}